Search research articles
Contact Us
Filters
Showing results (131-140 of 155) with videos related to
Page
of 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia
Francis Giles, Srdan Verstovsek, Deborah Thomas, et al.
Blood
|
January 10, 2016
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype
Nitin Jain, Audrey V Lamb, Susan O'Brien, et al.
British Journal of Haematology
|
April 3, 2004
Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome
Maha M T El-Zimaity, Hagop Kantarjian, Moshe Talpaz, et al.
Clinical Lymphoma & Myeloma
|
September 1, 2009
Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens
Jennifer L Kelly, Stephen R Toothaker, Lauren Ciminello, et al.
The Lancet. Oncology
|
February 24, 2012
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
Hagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia
William G Wierda, Susan O'Brien, Xuemei Wang, et al.
American Journal of Hematology
|
January 5, 2017
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission
Naveen Pemmaraju, Hagop Kantarjian, Jeffrey L Jorgensen, et al.
Blood
|
April 13, 2006
Lenalidomide therapy in myelofibrosis with myeloid metaplasia
Ayalew Tefferi, Jorge Cortes, Srdan Verstovsek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2014
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation
Yi Zhou, Rebecca Slack, Jeffrey L Jorgensen, et al.
Cancer Biology & Therapy
|
July 13, 2012
Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment
Olga Frolova, Ismael Samudio, Juliana Maria Benito, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 155) with videos related to
Sort By:
Page
of 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia
Francis Giles, Srdan Verstovsek, Deborah Thomas, et al.
Blood
|
January 10, 2016
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype
Nitin Jain, Audrey V Lamb, Susan O'Brien, et al.
British Journal of Haematology
|
April 3, 2004
Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome
Maha M T El-Zimaity, Hagop Kantarjian, Moshe Talpaz, et al.
Clinical Lymphoma & Myeloma
|
September 1, 2009
Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens
Jennifer L Kelly, Stephen R Toothaker, Lauren Ciminello, et al.
The Lancet. Oncology
|
February 24, 2012
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
Hagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia
William G Wierda, Susan O'Brien, Xuemei Wang, et al.
American Journal of Hematology
|
January 5, 2017
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission
Naveen Pemmaraju, Hagop Kantarjian, Jeffrey L Jorgensen, et al.
Blood
|
April 13, 2006
Lenalidomide therapy in myelofibrosis with myeloid metaplasia
Ayalew Tefferi, Jorge Cortes, Srdan Verstovsek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2014
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation
Yi Zhou, Rebecca Slack, Jeffrey L Jorgensen, et al.
Cancer Biology & Therapy
|
July 13, 2012
Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment
Olga Frolova, Ismael Samudio, Juliana Maria Benito, et al.
Page
of 16